Edlund, P.; Ahlgren, J.; Bjerre, K.; Andersson, M.; Bergh, J.; Mouridsen, H.; Holmberg, S. B.; Bengtsson, N.-O.; Jakobsen, E.; Møller, S. Dose-Tailoring of FEC Adjuvant Chemotherapy Based on Leukopenia Is Feasible and Well Tolerated. Toxicity and Dose Intensity in the Scandinavian Breast Group Phase 3 Adjuvant Trial SBG 2000-1. AO 2011, 50, 329-337.